Aarti Pharmalabs is an API manufacturer based in India. It holds 41 active US drug master files. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 27 March 2026 as VAI. Customs aggregates show $125.7M of exports covering 1,582 molecules to 72 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Thane, India | 3007005296 |
| Tarapur, India | 3005256484 |
| vapi 396 195valsad, India | Not on file |
| Vapi, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Mometasone Furoate | SFDA (Saudi Arabia), US FDA | 5 |
| Fluticasone Propionate | SFDA (Saudi Arabia), US FDA | 3 |
| Benazepril | US FDA | 2 |
| Cyclophosphamide | US FDA | 2 |
| Deferiprone | SFDA (Saudi Arabia), US FDA | 2 |
| Venlafaxine | US FDA | 2 |
| Adapalene | US FDA | 1 |
| Apixaban | US FDA | 1 |
| Azathioprine | US FDA | 1 |
| Bicalutamide | US FDA | 1 |
| Budesonide | US FDA | 1 |
| Bupropion | US FDA | 1 |
| Caffeine | US FDA | 1 |
| Capecitabine | US FDA | 1 |
| Ciclesonide | US FDA | 1 |
| Desonide | US FDA | 1 |
| Diflunisal | US FDA | 1 |
| Empagliflozin | US FDA | 1 |
| Enzalutamide | US FDA | 1 |
| Fluticasone Furoate | US FDA | 1 |
| Ifosfamide | US FDA | 1 |
| Ipratropium | US FDA | 1 |
| Levosalbutamol | US FDA | 1 |
| Loteprednol Etabonate | US FDA | 1 |
| Mercaptopurine | US FDA | 1 |
| Mesna | US FDA | 1 |
| Mirabegron | US FDA | 1 |
| Palbociclib | US FDA | 1 |
| Phenylephrine | US FDA | 1 |
| Quetiapine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 4 | None |
| CDSCO (India) | None | 2 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $20.1M | 44 |
| 2025 | $242.7M | $125.7M | 72 |
| 2024 | $221.4M | $89.9M | 72 |
| 2023 | $235.6M | $73.5M | 70 |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Aarti Pharmalabs comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.